COTA Healthcare’s Life Sciences Vice President Viraj Narayanan in a recent interview with Aetion discussed how oncological real-world data can be used to support clinical development.
Narayanan says COTA’s RWD set houses data from a “mix of academic and community sites.”
There are still obstacles ahead for sponsors looking to adopt real-world evidence, however.
“I’d say there are three layers of challenges we see sponsors face: challenges with data, the organizational or cultural appetite for RWE, and the process of establishing an overarching strategy for using real-world evidence,” he said.
To read the full discussion on Aetion’s site, click here.